Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16
Published September 20, 2023 · Recall initiated: August 30, 2023
Summary
FDA records drug Class II recall D-1149-2023, published September 20, 2023 and initiated August 30, 2023. Recalling firm: VistaPharm LLC; Status: Terminated; Reported quantity: 14,400 bottles; Lot: Lot #: 921100; Exp. 02/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
What to do
Voluntary: Firm initiated · Letter
Get an email if SUCRALFATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SUCRALFATE
- Manufacturer
- VistaPharm LLC
- Distributor
- Distributed nationwide to 68 consignees in the U.S.
- UPC
- 0366689305165
- Lot
- Lot #: 921100; Exp. 02/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only,October 25, 2023
- FDAPantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10September 20, 2023
- FDAWEFUN Capsules 825 mg, 1x10 blister pack per carton, Manufactured by WEFUN Brooklyn NY 11204September 20, 2023
- FDAZespri Organic Green Kiwi, product of New Zealand, one pallet of bulk loose organic green kiwifruit wasSeptember 20, 2023
- FDARuby Mountain Spring Water 3 and 5 gallon plastic water jugsSeptember 13, 2023
- FDANestle Toll House, Chocolate Chip Cookie Dough, 16.5 oz. Cookie dough in bar form packaged in paperboard traySeptember 13, 2023
Questions about this recall
Was Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16 recalled?
Yes. FDA published recall D-1149-2023 on September 20, 2023. Reported hazard: Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SUCRALFATE. UPC: 0366689305165.